New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
05:36 EDTAMPEAmpio incorporates Luoxis Diagnostics, COO Josh Disbrow to be CEO if Luoxis
Ampio Pharmaceuticals announced the incorporation and initiation of operations of Luoxis Diagnostics, a subsidiary of Ampio that will initially be funded through a private placement, with Ampio maintaining approximately 80% ownership post financing. Josh Disbrow, Ampio's COO, will assume the role of CEO of Luoxis. Details about the private placement will follow in the near future.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
13:55 EDTAMPEAmpio mentioned cautiously by Seeking Alpha contributor
Reference Link
January 22, 2015
08:04 EDTAMPEAmpio subsidiary secures European distribution for RedoxSYS diagnostic system
Ampio subsidiary Luoxis Diagnostics has secured long-term agreements with European distributors Eurobio, Una Health Limited, and THP Medical, to offer Luoxis' RedoxSYS Diagnostic System to academic and pharma-based research centers within their respective territories. RedoxSYS is a diagnostic platform and robust research tool capable of measuring oxidation-reduction potential in the body in response to injury, illness, or stress. Eurobio was granted territorial rights to offer RedoxSYS to institutions based in France and Switzerland, while Una Health Limited and THP Medical were granted territorial rights to the U.K. and Austria, respectively. These are multi-year agreements with the option to renew at the 3-5 year mark.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use